IL-17A inhibitor monoclonal antibody
This page covers all IL-17A inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-17A.
Targets
Phase 3 pipeline (2)
- BCD-063 · Biocad · Immunology
BCD-063 is a monoclonal antibody that binds to and inhibits IL-17A, a pro-inflammatory cytokine involved in autoimmune and inflammatory diseases. - JNJ-79635322 · Janssen Research & Development, LLC · Immunology
JNJ-79635322 is a monoclonal antibody that targets and inhibits IL-17A, a pro-inflammatory cytokine involved in immune-mediated inflammatory diseases.